Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity.
1999601 citationsHideaki Kaneto, Yoshitaka Kajimoto et al.Diabetesprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of J Miyagawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Miyagawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Miyagawa more than expected).
This network shows the impact of papers produced by J Miyagawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Miyagawa. The network helps show where J Miyagawa may publish in the future.
Co-authorship network of co-authors of J Miyagawa
This figure shows the co-authorship network connecting the top 25 collaborators of J Miyagawa.
A scholar is included among the top collaborators of J Miyagawa based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with J Miyagawa. J Miyagawa is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
10 of 10 papers shown
1.
Katsuno, Tomoyuki, Tomoya Hamaguchi, J Miyagawa, et al.. (2010). Asymmetric dimetylarginine (ADMA) could affect on cardiovascular complications in type 2 diabetes, particularly complicated with nephropathy. Endocrine Journal. 57. 378.1 indexed citations
Imagawa, Akihisa, Toshiaki Hanafusa, Hideichi Makino, J Miyagawa, & Per Juto. (2005). High titres of IgA antibodies to enterovirus in fulminant type-1 diabetes. Diabetologia.2 indexed citations
Kaneto, Hideaki, Yoshitaka Kajimoto, J Miyagawa, et al.. (1999). Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity.. Diabetes. 48(12). 2398–2406.601 indexed citations breakdown →
8.
Yoshida, S., Shunichi Yamashita, K Tokunaga, et al.. (1996). Visceral fat accumulation and vascular complications associated with VMH lesioning of spontaneously non-insulin-dependent diabetic GK rat.. PubMed. 20(10). 909–16.10 indexed citations
9.
Imagawa, Akihisa, Naoto Itoh, Toshiaki Hanafusa, et al.. (1996). High prevalence of antibodies to glutamic acid decarboxylase in comparison to islet cell antibodies in patients with long-standing insulin-dependent diabetes mellitus.. PubMed. 92(1). 43–52.8 indexed citations
10.
Nakajima, Hisakazu, Yoshihiro Tochino, Hiroko Fujino-Kurihara, et al.. (1985). Decreased incidence of diabetes mellitus by monosodium glutamate in the non-obese diabetic (NOD) mouse.. PubMed. 50(2). 251–7.10 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.